$0.21
Kintara Therapeutics is a biotechnology business based in the US. Kintara Therapeutics shares (KTRA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.23 – an increase of 22.11% over the previous week. Kintara Therapeutics employs 1 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Kintara Therapeutics stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Kintara Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – KTRA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Kintara Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Kintara Therapeutics stock price (NASDAQ: KTRA)
Use our graph to track the performance of KTRA stocks over time.Kintara Therapeutics shares at a glance
Latest market close | $0.23 |
---|---|
52-week range | $0.08 - $4.59 |
50-day moving average | $0.19 |
200-day moving average | $0.17 |
Wall St. target price | $14.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.32 |
Is it a good time to buy Kintara Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kintara Therapeutics price performance over time
Historical closes compared with the close of $0.1979 from 2024-10-14
1 week (2024-10-10) | 12.32% |
---|---|
1 month (2024-09-17) | 3.56% |
3 months (2024-07-17) | -27.16% |
6 months (2024-04-17) | 90.66% |
1 year (2023-10-17) | -94.68% |
---|---|
2 years (2022-10-17) | 110.53% |
3 years (2021-10-15) | 0.865 |
5 years (2019-10-17) | 0.5186 |
Kintara Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -103.76% |
Return on equity TTM | -370.77% |
Profit margin | 0% |
Book value | $-0.12 |
Market Capitalization | $12.6 million |
TTM: trailing 12 months
Kintara Therapeutics share dividends
We're not expecting Kintara Therapeutics to pay a dividend over the next 12 months.
Have Kintara Therapeutics's shares ever split?
Kintara Therapeutics's shares were split on a 1:50 basis on 13 November 2022. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kintara Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Kintara Therapeutics shares which in turn could have impacted Kintara Therapeutics's share price.
Kintara Therapeutics share price volatility
Over the last 12 months, Kintara Therapeutics's shares have ranged in value from as little as $0.081 up to $4.5861. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kintara Therapeutics's is 0.812. This would suggest that Kintara Therapeutics's shares are less volatile than average (for this exchange).
Kintara Therapeutics overview
Kintara Therapeutics, Inc. , a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China.
Frequently asked questions
What percentage of Kintara Therapeutics is owned by insiders or institutions?Currently 0.123% of Kintara Therapeutics shares are held by insiders and 1.472% by institutions. How many people work for Kintara Therapeutics?
Latest data suggests 1 work at Kintara Therapeutics. When does the fiscal year end for Kintara Therapeutics?
Kintara Therapeutics's fiscal year ends in June. Where is Kintara Therapeutics based?
Kintara Therapeutics's address is: 9920 Pacific Heights Blvd, San Diego, CA, United States, 92121 What is Kintara Therapeutics's ISIN number?
Kintara Therapeutics's international securities identification number is: US49720K1016
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question